|
40 Companies |
|
26 Products |
|
26 Products |
|
26 Mechanisms of Action |
|
1 Trial |
|
852 News |
|
| «12345678910111213...1718» |
- | Enrollment open, Trial primary completion date: Buspirone for Functional Dysphagia (clinicaltrials.gov) - Mar 14, 2017
P=N/A, N=20, Enrolling by invitation, Sponsor: The Cleveland Clinic
Not yet recruiting --> Enrolling by invitation | Trial primary completion date: Feb 2017 --> Jun 2017
- | New trial, Surgery, Bariatric surgery: Study of Gastro-oesophageal Reflux in Patients Having Had Bariatric Surgery (clinicaltrials.gov) - Mar 13, 2017
P=N/A, N=400, Not yet recruiting, Sponsor: Pierre Wauthy
- ||| Trial completion: Proton Pump Inhibitor Empirical Treatment in Management of Outpatients With Gastroesophageal Reflux Disease. (clinicaltrials.gov) - Mar 6, 2017
P=N/A, N=1000, Completed, Sponsor: AstraZeneca
Not yet recruiting --> Enrolling by invitation | Trial primary completion date: Feb 2017 --> Jun 2017 Active, not recruiting --> Completed
- | Victoza (liraglutide) / Novo Nordisk, Lyxumia (lixisenatide) / Zealand Pharma, Sanofi
Trial initiation date: Effects of Victoza (clinicaltrials.gov) - Mar 3, 2017
P1, N=72, Active, not recruiting, Sponsor: Profil Institut f
Active, not recruiting --> Completed Initiation date: Feb 2015 --> Jul 2015
- | New trial: Consequences of an Initial Treatment for Head and Neck Cancer on Swallowing Function: Impact on Nutritional Status (clinicaltrials.gov) - Mar 3, 2017
P=N/A, N=240, Active, not recruiting, Sponsor: Centre Antoine Lacassagne
- | Trial completion, Enrollment change: Prospective Trial on the Clinical Feasibility of a New Full Thickness Endoscopic Plication Device for Patients With GERD. (clinicaltrials.gov) - Mar 1, 2017
P=N/A, N=40, Completed, Sponsor: Krankenhaus Barmherzige Schwestern Linz
Initiation date: Feb 2015 --> Jul 2015 Recruiting --> Completed | N=80 --> 40
- ||| omeprazole / Generic mfg.
Enrollment closed: The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux Disease (clinicaltrials.gov) - Feb 27, 2017
P4, N=150, Active, not recruiting, Sponsor: Torax Medical Incorporated
Recruiting --> Completed | N=80 --> 40 Recruiting --> Active, not recruiting
- | Trial primary completion date: A Pilot Study of Acupuncture Treatment for Dysphagia (clinicaltrials.gov) - Feb 27, 2017
P=N/A, N=42, Completed, Sponsor: Dana-Farber Cancer Institute
Recruiting --> Active, not recruiting Trial primary completion date: Aug 2015 --> Jan 2013
- Trial primary completion date: Sleep Position May Reduce Acid Reflux Symptoms at Night (clinicaltrials.gov) - Feb 23, 2017
P=N/A, N=20, Enrolling by invitation, Sponsor: Vanderbilt University
Trial primary completion date: Aug 2015 --> Jan 2013 Trial primary completion date: Sep 2016 --> Sep 2017
- | Trial completion, Enrollment change, Trial primary completion date: Mucosal Impedance in Pediatric Population (clinicaltrials.gov) - Feb 23, 2017
P=N/A, N=127, Completed, Sponsor: Vanderbilt University
Trial primary completion date: Sep 2016 --> Sep 2017 Recruiting --> Completed | N=198 --> 127 | Trial primary completion date: Dec 2016 --> Sep 2016
- | Trial completion, Enrollment change, Trial primary completion date, Reflex: Cough Reflex Sensitivity and Bronchial Hyper-responsiveness (clinicaltrials.gov) - Feb 17, 2017
P=N/A, N=24, Completed, Sponsor: Mayo Clinic
Recruiting --> Completed | N=198 --> 127 | Trial primary completion date: Dec 2016 --> Sep 2016 Recruiting --> Completed | N=36 --> 24 | Trial primary completion date: Dec 2016 --> Feb 2016
- New trial: CR-GER: Gastroesophageal Reflux and Cardiorespiratory Problems (clinicaltrials.gov) - Feb 15, 2017
P=N/A, N=72, Completed, Sponsor: University of Turin, Italy
- New P2 trial: Effect of Oral Menthol on the Swallow Response of Patients With Oropharyngeal Dysphagia Associated With Neurological Diseases and Aging (clinicaltrials.gov) - Feb 13, 2017
P2, N=38, Completed, Sponsor: Hospital de Mataró
- Biomarker, Enrollment open: Pharmacogenetic Testing in Children With Persistent Gastroesophageal Reflux Disease (clinicaltrials.gov) - Feb 13, 2017
P=N/A, N=30, Recruiting, Sponsor: Mayo Clinic
Recruiting --> Completed | N=36 --> 24 | Trial primary completion date: Dec 2016 --> Feb 2016 Not yet recruiting --> Recruiting
- | Phase classification: Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD) (clinicaltrials.gov) - Feb 12, 2017
P=N/A, N=500, Active, not recruiting, Sponsor: EndoGastric Solutions
Not yet recruiting --> Recruiting Phase classification: P4 --> P=N/A
- Enrollment open: The Turkish Feeding/Swallowing Impact Survey (clinicaltrials.gov) - Feb 10, 2017
P=N/A, N=150, Recruiting, Sponsor: Hacettepe University
Phase classification: P4 --> P=N/A Not yet recruiting --> Recruiting
- New trial, MRI: Dysphagia After Different Swallowing Therapies (clinicaltrials.gov) - Feb 9, 2017
P=N/A, N=58, Completed, Sponsor: Chang Gung Memorial Hospital
- esomeprazole / Generic mfg.
Trial completion, Enrollment change: The Gastrointestinal Microbiome of Infants With GERD and PPI Therapy: a Pilot Study (clinicaltrials.gov) - Feb 8, 2017
P=N/A, N=12, Completed, Sponsor: Medical University of Graz
Not yet recruiting --> Recruiting Recruiting --> Completed | N=20 --> 12
- || omeprazole / Generic mfg.
Trial primary completion date: The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux Disease (clinicaltrials.gov) - Feb 6, 2017
P4, N=150, Recruiting, Sponsor: Torax Medical Incorporated
Recruiting --> Completed | N=20 --> 12 Trial primary completion date: Jun 2017 --> Feb 2018
- Phase classification: RELIEF Europe Study (clinicaltrials.gov) - Feb 6, 2017
P=N/A, N=7, Terminated, Sponsor: Torax Medical Incorporated
Trial primary completion date: Jun 2017 --> Feb 2018 Phase classification: P4 --> P=N/A
- New P4 trial: Comparison of the Effect of Rabeprazole 50 mg DDR Capsules and 20 mg Enteric-coated Tablets (clinicaltrials.gov) - Jan 31, 2017
P4, N=48, Not yet recruiting, Sponsor: Neutec Ar-Ge San ve Tic A.Ş
- fluorouracil topical / Generic mfg., cisplatin / Generic mfg.
Trial primary completion date, HEOR, Metastases: Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia. (clinicaltrials.gov) - Jan 24, 2017
P3, N=220, Completed, Sponsor: Trans-Tasman Radiation Oncology Group (TROG)
Phase classification: P4 --> P=N/A Trial primary completion date: Jul 2012 --> Mar 2012
- New trial: Effect of Different Viscous Foods and Liquids on Swallowing Sounds (clinicaltrials.gov) - Jan 18, 2017
P=N/A, N=38, Not yet recruiting, Sponsor: University of Nebraska
- || omeprazole / Generic mfg.
Trial primary completion date: The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux Disease (clinicaltrials.gov) - Jan 13, 2017
P4, N=150, Recruiting, Sponsor: Torax Medical Incorporated
Trial primary completion date: Jul 2012 --> Mar 2012 Trial primary completion date: Dec 2016 --> Jun 2017
- Trial completion, Enrollment change, Trial primary completion date, Surgery: Prospective Pediatric Vesicoureteral Reflux Surgery Database (clinicaltrials.gov) - Jan 5, 2017
P=N/A, N=134, Completed, Sponsor: Connecticut Children's Medical Center
Trial primary completion date: Dec 2016 --> Jun 2017 Recruiting --> Completed | N=200 --> 134 | Trial primary completion date: Jul 2012 --> Nov 2016
- Trial completion: EVAKIN: Clinical Evaluation of Swallowing Disorders as a Predictor of Extubation Failure (clinicaltrials.gov) - Jan 4, 2017
P=N/A, N=160, Completed, Sponsor: Assistance Publique - H
Recruiting --> Completed | N=200 --> 134 | Trial primary completion date: Jul 2012 --> Nov 2016 Recruiting --> Completed
- Enrollment open, Enrollment change, Trial initiation date: Impact of Gastroesophageal Reflux and Aspiration on Airway Inflammation and Microbiome in Children With Chronic Cough (clinicaltrials.gov) - Jan 4, 2017
P=N/A, N=120, Recruiting, Sponsor: New York University School of Medicine
Recruiting --> Completed Not yet recruiting --> Recruiting | N=20 --> 120 | Initiation date: Mar 2017 --> Jun 2014
- Biomarker, New trial: Pharmacogenetic Testing in Children With Persistent Gastroesophageal Reflux Disease (clinicaltrials.gov) - Dec 29, 2016
P=N/A, N=30, Not yet recruiting, Sponsor: Mayo Clinic
- New trial: The Turkish Feeding/Swallowing Impact Survey (clinicaltrials.gov) - Dec 29, 2016
P=N/A, N=150, Not yet recruiting, Sponsor: Hacettepe University
- |||| K-CAB Tab (tegoprazan) / RaQualia, Sebela
Trial primary completion date: Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Non Erosive Reflux Disease (clinicaltrials.gov) - Dec 29, 2016
P3, N=324, Recruiting, Sponsor: CJ HealthCare Corporation
Not yet recruiting --> Recruiting | N=20 --> 120 | Initiation date: Mar 2017 --> Jun 2014 Trial primary completion date: Sep 2016 --> Jun 2017
- Trial initiation date: Impact of Gastroesophageal Reflux and Aspiration on Airway Inflammation and Microbiome in Children With Chronic Cough (clinicaltrials.gov) - Dec 28, 2016
P=N/A, N=20, Not yet recruiting, Sponsor: New York University School of Medicine
Trial primary completion date: Sep 2016 --> Jun 2017 Initiation date: Jul 2016 --> Mar 2017
- Trial completion, Trial primary completion date: The Pediatric Eating Assessment Tool (clinicaltrials.gov) - Dec 28, 2016
P=N/A, N=138, Completed, Sponsor: Hacettepe University
Initiation date: Jul 2016 --> Mar 2017 Recruiting --> Completed | Trial primary completion date: Jan 2017 --> Aug 2016
- || Enrollment closed: Proton Pump Inhibitor Empirical Treatment in Management of Outpatients With Gastroesophageal Reflux Disease. (clinicaltrials.gov) - Dec 20, 2016
P=N/A, N=1000, Active, not recruiting, Sponsor: AstraZeneca
Recruiting --> Completed | Trial primary completion date: Jan 2017 --> Aug 2016 Recruiting --> Active, not recruiting
- New trial: [Impedance Measurement for Non-Erosive Reflux Disease (clinicaltrials.gov) - Dec 20, 2016
P=N/A, N=40, Enrolling by invitation, Sponsor: Mayo Clinic
- Trial primary completion date: EMST and TMS for Treatment of Dysphagia in Parkinson's Disease (clinicaltrials.gov) - Dec 20, 2016
P=N/A, N=40, Recruiting, Sponsor: University Hospital Muenster
Recruiting --> Active, not recruiting Trial primary completion date: May 2017 --> Aug 2017
- Dexilant (dexlansoprazole) / Takeda
Phase classification: Can E-cadherin Found in Tissue/Blood be Valuable in Identifying & Monitoring Patients With Post-proton Pump Inhibitor (PPI)-Responsive Heartburn (clinicaltrials.gov) - Dec 19, 2016
P1, N=40, Completed, Sponsor: University of North Carolina, Chapel Hill
Trial primary completion date: May 2017 --> Aug 2017 Phase classification: P4 --> P1
- Trial completion, Trial primary completion date: EoE(Eosinophilic Esophagitis) (clinicaltrials.gov) - Dec 16, 2016
P=N/A, N=10, Completed, Sponsor: University of Michigan
Phase classification: P4 --> P1 Active, not recruiting --> Completed | Trial primary completion date: Dec 2017 --> Apr 2016
- Varithena (polidocanol injectable foam) / Boston Scientific
New trial: Effect of PEM Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in VLUs (clinicaltrials.gov) - Dec 9, 2016
P=N/A, N=60, Not yet recruiting, Sponsor: OhioHealth
- Enrollment change, Trial termination: RELIEF Europe Study (clinicaltrials.gov) - Dec 6, 2016
P4, N=7, Terminated, Sponsor: Torax Medical Incorporated
Active, not recruiting --> Completed | Trial primary completion date: Dec 2017 --> Apr 2016 N=100 --> 7 | Recruiting --> Terminated; Insufficient enrollment
- Trial primary completion date: The Pediatric Eating Assessment Tool (clinicaltrials.gov) - Dec 6, 2016
P=N/A, N=140, Recruiting, Sponsor: Hacettepe University
N=100 --> 7 | Recruiting --> Terminated; Insufficient enrollment Trial primary completion date: Sep 2016 --> Jan 2017
- Trial primary completion date: Efficacy of Natural Ingredient to Improve the Swallowing Response of Patients With Oropharyngeal Dysphagia (clinicaltrials.gov) - Dec 6, 2016
P=N/A, N=84, Recruiting, Sponsor: Nestl
Trial primary completion date: Sep 2016 --> Jan 2017 Trial primary completion date: Dec 2016 --> May 2017
- Victoza (liraglutide) / Novo Nordisk, Lyxumia (lixisenatide) / Zealand Pharma, Sanofi
Trial primary completion date: Effects of Victoza (clinicaltrials.gov) - Dec 1, 2016
P1, N=72, Active, not recruiting, Sponsor: Profil Institut f
Trial primary completion date: Dec 2016 --> May 2017 Trial primary completion date: Oct 2016 --> Mar 2017
- New trial: Benefit From the Chin Down Maneuver in the Swallowing Performance and Self-perception of Parkinson's Disease Patients (clinicaltrials.gov) - Nov 25, 2016
P=N/A, N=26, Completed, Sponsor: Hospital de Clinicas de Porto Alegre
- dexamethasone injection / Generic mfg.
Trial primary completion date, Surgery: DysDexVSSal: Dysphagia Following Anterior Cervical Spine Surgery; Steroid vs Saline (clinicaltrials.gov) - Nov 16, 2016
P=N/A, N=74, Active, not recruiting, Sponsor: West Virginia University
Trial primary completion date: Oct 2016 --> Mar 2017 Trial primary completion date: Sep 2016 --> May 2016
- || Trial primary completion date: Proton Pump Inhibitor Empirical Treatment in Management of Outpatients With Gastroesophageal Reflux Disease. (clinicaltrials.gov) - Nov 15, 2016
P=N/A, N=1000, Recruiting, Sponsor: AstraZeneca
Trial primary completion date: Sep 2016 --> May 2016 Trial primary completion date: Sep 2016 --> Jan 2017
- New trial, HEOR: NEQOL Survey Spanish Validation in a Hispanic Clinic Based Population (clinicaltrials.gov) - Nov 9, 2016
P=N/A, N=100, Recruiting, Sponsor: Carlos Robles-Medranda
- Trial completion, Enrollment change: Post Extubation Dysphagia (clinicaltrials.gov) - Nov 1, 2016
P=N/A, N=71, Completed, Sponsor: University of Wisconsin, Madison
Trial primary completion date: Sep 2016 --> Jan 2017 Recruiting --> Completed | N=100 --> 71
- Trial completion, Trial primary completion date: The Role That Peroral Endoscopic Myotomy (POEM) Could Play in the Treatment of Achalasia (clinicaltrials.gov) - Oct 31, 2016
P=N/A, N=20, Completed, Sponsor: Mayo Clinic
Recruiting --> Completed | N=100 --> 71 Enrolling by invitation --> Completed | Trial primary completion date: Sep 2017 --> Jan 2016
- Trial completion, Intubation: Screening for Swallowing Problems in Patients Following Prolonged Intubation: Validation of the Toronto Bedside Swallowing Screening Test (TOR-BSST (clinicaltrials.gov) - Oct 31, 2016
P=N/A, N=100, Completed, Sponsor: University Health Network, Toronto
Enrolling by invitation --> Completed | Trial primary completion date: Sep 2017 --> Jan 2016 Recruiting --> Completed
- ||| Trial completion, Enrollment change, Trial primary completion date: DysphagCerv: Dysphagia and Cervical Spine Disorders in Patients With Brain Lesions (clinicaltrials.gov) - Oct 26, 2016
P1, N=70, Completed, Sponsor: University of Ioannina
Recruiting --> Completed Recruiting --> Completed | N=100 --> 70 | Trial primary completion date: Nov 2015 --> Oct 2016